Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA

Severe acute respiratory syndrome (SARS)‐CoV is a newly emerging virus that causes SARS with high mortality rate in infected people. To study the humoral responses against SARS‐CoV, we evaluated nucleocapsid (N) and spike (S) proteins‐specific antibodies in patients' sera by Western blotting an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Med Virol
Autori principali: Huang, Li‐Rung, Chiu, Chi‐Ming, Yeh, Shiou‐Hwei, Huang, Wen‐Hung, Hsueh, Po‐Ren, Yang, Wen‐Zieh, Yang, Jyh‐Yuan, Su, Ih‐Jen, Chang, Shan‐Chwen, Chen, Pei‐Jer
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley Subscription Services, Inc., A Wiley Company 2004
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7167198/
https://ncbi.nlm.nih.gov/pubmed/15170626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.20096
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi